Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respiratory care devices in the U.S. but will allow for exports.
Source link
Philips shares climb after finalizing pact with U.S. over device sales
